Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Acemannan |
Is a |
True |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Tilorone |
Is a |
True |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Colony stimulating factor (substance) |
Is a |
True |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Product containing aldesleukin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Product containing amifostine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Product containing interleukin-11 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Immunostimulant poisoning |
Causative agent (attribute) |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
1 |
Accidental immunostimulant poisoning |
Causative agent (attribute) |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Intentional immunostimulant poisoning |
Causative agent (attribute) |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Immunostimulant poisoning of undetermined intent |
Causative agent (attribute) |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
1 |
Immunostimulant adverse reaction |
Causative agent (attribute) |
True |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
1 |
Amifostine adverse reaction |
Causative agent (attribute) |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Aldesleukin adverse reaction (disorder) |
Causative agent (attribute) |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Levamisole adverse reaction |
Causative agent (attribute) |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Immunostimulant allergy |
Causative agent (attribute) |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Allergy to amifostine (finding) |
Causative agent (attribute) |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Allergy to aldesleukin |
Causative agent (attribute) |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Allergy to levamisole |
Causative agent (attribute) |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Immunostimulant overdose |
Causative agent (attribute) |
True |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
1 |
Accidental immunostimulant overdose |
Causative agent (attribute) |
True |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
1 |
Intentional immunostimulant overdose |
Causative agent (attribute) |
True |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
1 |
Immunostimulant overdose of undetermined intent |
Causative agent (attribute) |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
1 |
Levamisole HCl [immunostimulant] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Product containing precisely levamisole 50 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Amifostine 375 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Interleukins |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Aldesleukin 18megaunits powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Amifostine 500mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Product containing levamisole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Immune enhancement agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Amifostine 500 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Product containing oprelvekin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Oprelvekin 5mg powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Interferon |
Is a |
True |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Aldesleukin (substance) |
Is a |
True |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Amifostine (substance) |
Is a |
True |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Levamisole (substance) |
Is a |
True |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Accidental immunostimulant poisoning |
Causative agent (attribute) |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
1 |
Intentional immunostimulant poisoning |
Causative agent (attribute) |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
1 |
Thalidomide |
Is a |
True |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Plerixafor |
Is a |
True |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Immunostimulant allergy |
Causative agent (attribute) |
False |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
1 |
Pidotimod |
Is a |
True |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Thymostimulin (substance) |
Is a |
True |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Levamisole resinate |
Is a |
True |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|
Levamisole hydrochloride |
Is a |
True |
Immune enhancement agent (substance) |
Inferred relationship |
Some |
|